Because Neu-YB tumor cells have been shown to express more CXCL12 than the other mutants and Neu-NDL [14], we investigated whether CXCR4 signaling plays a role in EGF-induced in vivo invasion in that tumor. This evidence concerns the gene CXCL12 and neoplasm.